GlobeNewswire Inc.··NaNovo Nordisk Showcases Obesity Portfolio at European Congress With Wegovy Data, CagriSema Focus
Novo Nordisk will present 52 abstracts on Wegovy and experimental CagriSema at European obesity congress, highlighting cardiovascular benefits and women's health data.
NVOclinical dataweight loss